SG Americas Securities, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$54,000
-46.5%
11,657
+2.9%
0.00%
-100.0%
Q3 2017$101,000
-26.8%
11,324
+3.8%
0.00%0.0%
Q2 2017$138,000
-24.6%
10,909
-4.6%
0.00%0.0%
Q1 2016$183,000
+4.0%
11,435
+86.4%
0.00%0.0%
Q4 2015$176,000
-10.7%
6,134
-11.4%
0.00%0.0%
Q3 2015$197,000
-71.7%
6,923
-64.2%
0.00%
-80.0%
Q2 2015$695,000
+20.0%
19,362
+94.5%
0.01%
+66.7%
Q1 2015$579,000
+36.9%
9,953
-0.7%
0.00%
+50.0%
Q4 2014$423,000
+185.8%
10,025
+163.3%
0.00%
+100.0%
Q3 2014$148,0003,8080.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders